1. Home
  2. MDXH vs MTEN Comparison

MDXH vs MTEN Comparison

Compare MDXH & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • MTEN
  • Stock Information
  • Founded
  • MDXH 2003
  • MTEN 2015
  • Country
  • MDXH Belgium
  • MTEN China
  • Employees
  • MDXH N/A
  • MTEN N/A
  • Industry
  • MDXH
  • MTEN Building Products
  • Sector
  • MDXH
  • MTEN Industrials
  • Exchange
  • MDXH Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • MDXH 84.6M
  • MTEN 97.9M
  • IPO Year
  • MDXH 2021
  • MTEN 2024
  • Fundamental
  • Price
  • MDXH $2.00
  • MTEN $12.02
  • Analyst Decision
  • MDXH Buy
  • MTEN
  • Analyst Count
  • MDXH 1
  • MTEN 0
  • Target Price
  • MDXH $6.00
  • MTEN N/A
  • AVG Volume (30 Days)
  • MDXH 73.0K
  • MTEN 39.3K
  • Earning Date
  • MDXH 05-14-2025
  • MTEN 04-30-2025
  • Dividend Yield
  • MDXH N/A
  • MTEN N/A
  • EPS Growth
  • MDXH N/A
  • MTEN N/A
  • EPS
  • MDXH N/A
  • MTEN N/A
  • Revenue
  • MDXH $94,507,000.00
  • MTEN $10,120,257.00
  • Revenue This Year
  • MDXH $23.50
  • MTEN N/A
  • Revenue Next Year
  • MDXH $17.30
  • MTEN N/A
  • P/E Ratio
  • MDXH N/A
  • MTEN N/A
  • Revenue Growth
  • MDXH 25.46
  • MTEN 23.03
  • 52 Week Low
  • MDXH $1.35
  • MTEN $1.81
  • 52 Week High
  • MDXH $3.50
  • MTEN $16.60
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 48.51
  • MTEN N/A
  • Support Level
  • MDXH $2.07
  • MTEN N/A
  • Resistance Level
  • MDXH $2.21
  • MTEN N/A
  • Average True Range (ATR)
  • MDXH 0.12
  • MTEN 0.00
  • MACD
  • MDXH -0.02
  • MTEN 0.00
  • Stochastic Oscillator
  • MDXH 11.76
  • MTEN 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: